harmacare
Patient Safety
Adverse Drug Reactions in Canada (2009–2018): Insights from the Canada Vigilance Database
Tuhin S. Maity and Christopher J. Longo
Research Papers
An Exploratory Analysis of Predictors of Concordance Between Canadian Common Drug Review Reimbursement Recommendations and the Subsequent Decisions by Ontario, British Columbia and Alberta
Michael J. Zoratti, Feng Xie, Kristian Thorlund, Nicola Allen and Mitchell Levine
Research Paper
Policies for Deprescribing: An International Scan of Intended and Unintended Outcomes of Limiting Sedative-Hypnotic Use in Community-Dwelling Older Adults
James Shaw, Andrea L. Murphy, Justin P. Turner, David M. Gardner, James L. Silvius, Zachary Bouck, D...
Discussion and Debate
Increase in Drug Spending in Canada Due to Extension of Data Protection for Biologics: A Descriptive Study
Joel Lexchin
Public Opinions on Pharmacare
Healthcare in Canada: Choices Going Forward
Terrence Montague, Bonnie Cochrane, Amédé Gogovor, John Aylen, Lesli Martin and Joanna Nemis-White
From the Editors
From the Editors
Discussion and Debate
Ontario and New Zealand Pharmaceuticals: Cost and Coverage
Leah T. Kelley, Tim Tenbensel and Ana Johnson